Clinical trial launched to improve diabetes management in Chinese Americans


A news conference will announce the opportunity to participate in a clinical trial testing the effectiveness of culturally specific programs for Type 2 diabetes in Chinese Americans.

Among other criteria, participants must be first-generation Chinese at least 21 years of age and have a diagnosis of Type 2 diabetes.

The trial is one phase of a four-year $1 million NIH grant.  It involves academic and community agency partners committed to improve diabetes management in the Chinese American population: UCSF, University of San Francisco, Donaldina Cameron House and North East Medical Services.

Donaldina Cameron House


Wednesday, May 20, 2009
11:00 a.m. – Noon


Donaldina Cameron House
920 Sacramento St., San Francisco


Though Asian Americans tend to be less obese (a risk factor for diabetes), they are almost twice as likely to develop type 2 diabetes than Caucasian Americans, according to the Joslin Diabetes Center. However, health research on Asian Americans has lagged behind research on other ethnic groups, reports an article in Health Education & Behavior. Special Issue: Health Disparities, 2006. 33(4):p.459-469.


·      Introduction: Kevin Chun, PhD, co-principal investigator, professor of psychology, University of San Francisco
·      Overview of study: Catherine Chesla, RN, DNSc, FAAN, principal investigator, professor of family health care nursing, UCSF School of Nursing
·      Honorable David Chiu, president of the San Francisco Board of Supervisors, District 3 supervisor
·      Yulanda Kwong, MSW, director of social services, Donaldina Cameron House
·      Daniel Chan, MD, director of quality assurance, North East Medical Services
·      Testimonials from two Chinese Americans from first study phase

MEDIA CONTACT: Karin Rush-Monroe, UCSF News Office, 415-476-2557. On the day of the event, call cell phone 415-244-5402.